116 related articles for article (PubMed ID: 12834817)
21. NAD(P)H:quinone oxidoreductase 1 (NQO1) P187S polymorphism and prostate cancer risk in Caucasians.
Stoehr CG; Nolte E; Wach S; Wieland WF; Hofstaedter F; Hartmann A; Stoehr R
Int J Mol Sci; 2012; 13(9):10959-10969. PubMed ID: 23109831
[TBL] [Abstract][Full Text] [Related]
22. No associations between Parkinson's disease and polymorphisms of the quinone oxidoreductase (NQO1, NQO2) genes.
Okada S; Farin FM; Stapleton P; Viernes H; Quigley SD; Powers KM; Smith-Weller T; Franklin GM; Longstreth WT; Swanson PD; Checkoway H
Neurosci Lett; 2005 Mar; 375(3):178-80. PubMed ID: 15694256
[TBL] [Abstract][Full Text] [Related]
23. [The NAD(P)H: quinone oxidoreductase 1 C609T polymorphism and susceptibility to esophageal cancer].
Zhang JH; Li Y; Wang R; Sarbia M; Guo W; Wen DG; Wei LZ; Chen ZF; Kuang G; Zhang LW; He M; Wu ML; Wang SJ
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Dec; 20(6):544-6. PubMed ID: 14669229
[TBL] [Abstract][Full Text] [Related]
24. Polymorphisms in the NAD(P)H: quinone oxidoreductase gene and small cell lung cancer risk in a UK population.
Lewis SJ; Cherry NM; Niven RM; Barber PV; Povey AC
Lung Cancer; 2001 Nov; 34(2):177-83. PubMed ID: 11679176
[TBL] [Abstract][Full Text] [Related]
25. Association between polymorphisms in the genes for tumor suppressor protein p53 and its regulator NAD(P)H: quinone oxidoreductase 1 (NQO1) and schizophrenia in a Syrian study cohort.
Lajin B; Alachkar A; Michati R; Alhaj Sakur A
Arch Med Res; 2013 Feb; 44(2):121-6. PubMed ID: 23360829
[TBL] [Abstract][Full Text] [Related]
26. Genetic polymorphism 609C>T in NAD(P)H:quinone oxidoreductase 1 enhances the risk of proximal colon cancer.
Freriksen JJ; Salomon J; Roelofs HM; Te Morsche RH; van der Stappen JW; Dura P; Witteman BJ; Lacko M; Peters WH
J Hum Genet; 2014 Jul; 59(7):381-6. PubMed ID: 24830960
[TBL] [Abstract][Full Text] [Related]
27. NAD(P)H:quinone oxidoreductase 1: role as a superoxide scavenger.
Siegel D; Gustafson DL; Dehn DL; Han JY; Boonchoong P; Berliner LJ; Ross D
Mol Pharmacol; 2004 May; 65(5):1238-47. PubMed ID: 15102952
[TBL] [Abstract][Full Text] [Related]
28. NAD(P)H quinone oxidoreductase 1 codon 609 polymorphism and its association to colorectal cancer.
Harth V; Donat S; Ko Y; Abel J; Vetter H; Brüning T
Arch Toxicol; 2000 Jan; 73(10-11):528-31. PubMed ID: 10663383
[TBL] [Abstract][Full Text] [Related]
29. Association analysis of NAD(P)H:quinone oxidoreductase gene 609 C/T polymorphism with Alzheimer's disease.
Wang B; Jin F; Xie Y; Tang Y; Kan R; Zheng C; Yang Z; Wang L
Neurosci Lett; 2006 Dec; 409(3):179-81. PubMed ID: 17027152
[TBL] [Abstract][Full Text] [Related]
30. Oxidative stress in tardive dyskinesia: genetic association study and meta-analysis of NADPH quinine oxidoreductase 1 (NQO1) and Superoxide dismutase 2 (SOD2, MnSOD) genes.
Zai CC; Tiwari AK; Basile V; de Luca V; Müller DJ; Voineskos AN; Remington G; Meltzer HY; Lieberman JA; Potkin SG; Kennedy JL
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):50-6. PubMed ID: 19778569
[TBL] [Abstract][Full Text] [Related]
31. [A study on the relationship between polymorphism of human NAD(P)H: quinone oxidoreductase and Parkinson's disease in Chinese].
Jiang XH; Yang H; Yang JF; Wang HT; Xu QY; Chen B
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Apr; 21(2):120-3. PubMed ID: 15079792
[TBL] [Abstract][Full Text] [Related]
32. No association between Helicobacter pylori seropositivity and ornithine decarboxylase (ODC) A317G polymorphism, and no modification by NAD(P)H:qinone oxidoreductase 1 (NQO1) C609T.
Goto Y; Nishio K; Ishida Y; Kawai S; Osafune T; Naito M; Katsuda N; Hamajima N
Nagoya J Med Sci; 2007 Jan; 69(1-2):17-22. PubMed ID: 17378176
[TBL] [Abstract][Full Text] [Related]
33. Nucleotide and deduced amino acid sequence of a human cDNA (NQO2) corresponding to a second member of the NAD(P)H:quinone oxidoreductase gene family. Extensive polymorphism at the NQO2 gene locus on chromosome 6.
Jaiswal AK; Burnett P; Adesnik M; McBride OW
Biochemistry; 1990 Feb; 29(7):1899-906. PubMed ID: 1691923
[TBL] [Abstract][Full Text] [Related]
34. NAD(P)H: quinone oxidoreductase 1 and its potential protective role in cardiovascular diseases and related conditions.
Zhu H; Li Y
Cardiovasc Toxicol; 2012 Mar; 12(1):39-45. PubMed ID: 21818552
[TBL] [Abstract][Full Text] [Related]
35. Association between NAD(P)H: quinone oxidoreductase 1 (NQ01) inactivating C609T polymorphism and adenocarcinoma of the upper gastrointestinal tract.
Sarbia M; Bitzer M; Siegel D; Ross D; Schulz WA; Zotz RB; Kiel S; Geddert H; Kandemir Y; Walter A; Willers R; Gabbert HE
Int J Cancer; 2003 Nov; 107(3):381-6. PubMed ID: 14506737
[TBL] [Abstract][Full Text] [Related]
36. Investigation of NAD(P)H:quinone oxidoreductase 1 (NQO1) C609T polymorphism in prostate cancer.
Ergen HA; Gormus U; Narter F; Zeybek U; Bulgurcuoglu S; Isbir T
Anticancer Res; 2007; 27(6B):4107-10. PubMed ID: 18225579
[TBL] [Abstract][Full Text] [Related]
37. Association analyses between polymorphisms of the phase II detoxification enzymes (GSTM1, NQO1, NQO2) and alcohol withdrawal symptoms.
Okubo T; Harada S; Higuchi S; Matsushita S
Alcohol Clin Exp Res; 2003 Aug; 27(8 Suppl):68S-71S. PubMed ID: 12960511
[TBL] [Abstract][Full Text] [Related]
38. Association of NAD(P)H:quinone oxidoreductase (NQO1) null with numbers of basal cell carcinomas: use of a multivariate model to rank the relative importance of this polymorphism and those at other relevant loci.
Clairmont A; Sies H; Ramachandran S; Lear JT; Smith AG; Bowers B; Jones PW; Fryer AA; Strange RC
Carcinogenesis; 1999 Jul; 20(7):1235-40. PubMed ID: 10383895
[TBL] [Abstract][Full Text] [Related]
39. NAD(P)H: quinone oxidoreductase polymorphism and lung cancer in Taiwan.
Lin P; Wang HJ; Lee H; Lee HS; Wang SL; Hsueh YM; Tsai KJ; Chen CY
J Toxicol Environ Health A; 1999 Oct; 58(4):187-97. PubMed ID: 10591487
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of NAD(P)H:quinone oxidoreductase 1 (NQO1) and genomic gain of the NQO1 locus modulates breast cancer cell sensitivity to quinones.
Glorieux C; Sandoval JM; Dejeans N; Ameye G; Poirel HA; Verrax J; Calderon PB
Life Sci; 2016 Jan; 145():57-65. PubMed ID: 26687450
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]